Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guizhou Shiling Pharmaceutical is a pharmaceutical manufacturing enterprise located in Anshun, Guizhou Province, China. Founded in 2014, the company focuses on the production of chemical generic drugs and Traditional Chinese Medicine (TCM) preparations. Its facility is GMP-certified and includes production lines for capsules, tablets, and granules, as well as specialized TCM extraction capabilities. Key products in its portfolio include anti-infectives like Amoxicillin and Norfloxacin, as well as respiratory treatments such as Compound Paracetamol and Amantadine Hydrochloride capsules. The company also produces botanical extracts, including Ginkgo Biloba, targeting cardiovascular health. Guizhou Shiling Pharmaceutical primarily serves the healthcare needs of the domestic Chinese market through the supply of essential medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 贵州世领制药.